动态MRI影像组学模型早期预测局部晚期宫颈癌同步放化疗预后
本研究回顾性纳入111例接受同步放化疗的局部晚期宫颈癌患者,在基线、近距离放疗前及随访时采集动态MRI,用LASSO提取特征并构建SVM模型。ΔMRImid影像组学模型在测试集预测2年无进展生存和总生存的AUC分别为0.759和0.789,联合临床特征后提升至0.812和0.868。
要点
- 多序列模型优于单序列模型,MRImid模型优于治疗后模型。
- ΔMRImid模型预测2年PFS和OS的AUC分别为0.759和0.789。
- 联合临床特征后ΔMRImid模型AUC提升至0.812和0.868。
核心结论
- 基于纵向图像动态特征构建的机器学习模型中,ΔMRImid模型可作为无创指标早期预测接受同步放化疗的局部晚期宫颈癌患者预后。
- 联合临床特征的整合模型进一步提升了预测性能。
研究设计与样本
- 回顾性纳入111例局部晚期宫颈癌患者,训练集88例,测试集23例。
- 在基线(MRIpre)、近距离放疗前(MRImid)及每次随访时采集动态MRI。
- 评估临床特征、2年无进展生存和2年总生存。
- 采用LASSO方法从MR图像及临床特征中提取特征,训练支持向量机模型并在测试集评估。
主要发现
- 多序列模型性能优于单序列模型。
- 基于MRImid的影像组学模型在预测局部晚期宫颈癌患者预后方面优于治疗后模型。
- 测试集中,MRIpre、MRImid和ΔMRImid影像组学模型预测2年无进展生存的AUC分别为0.723、0.750和0.759。
- 测试集中,MRIpre、MRImid和ΔMRImid影像组学模型预测2年总生存的AUC分别为0.711、0.737和0.789。
- 联合临床特征后,ΔMRImid预测模型性能优于其他模型,预测进展的AUC为0.812,预测生存的AUC为0.868。
关键数值与推荐
- ΔMRImid影像组学模型预测2年无进展生存的AUC为0.759,预测2年总生存的AUC为0.789。
- ΔMRImid联合临床特征模型预测进展的AUC为0.812,预测生存的AUC为0.868。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the early predictive value of dynamic magnetic resonance imaging (MRI)-based radiomics for progression and prognosis in locally advanced cervical cancer (LACC) patients treated with concurrent chemoradiotherapy (CCRT). METHODS AND MATERIALS: A total of 111 LACC patients (training set: 88; test set: 23) were retrospectively enrolled. Dynamic MR images were acquired at baseline (MRIpre), before brachytherapy delivery (MRImid) and at each follow-up visit. Clinical characteristics, 2-year progression-free survival (PFS), and 2-year overall survival (OS) were evaluated. The least absolute shrinkage and selection operator (LASSO) method was applied to extract features from MR images as well as from clinical characteristics. The support vector machine (SVM) model was trained on the training set and then evaluated on the test set. RESULTS: Compared with single-sequence models, multisequence models exhibited superior performance. MRImid-based radiomics models performed better in predicting the prognosis of LACC patients than the post-treatment did. The MRIpre-, MRImid- and the ΔMRImid (variations in radiomics features from MRIpre and MRImid) -based radiomics models achieve AUC scores of 0.723, 0.750 and 0.759 for 2-year PFS and 0.711, 0.737 and 0.789 for 2-year OS in the test set. When combined with the clinical characteristics, the ΔMRImid-based predictive model also performed better than the other models did, with an AUC of 0.812 for progression and 0.868 for survival. CONCLUSION: We built machine learning models from dynamic features in longitudinal images and found that the ΔMRImid-based model can serve as a non-invasive indicator for the early prediction of prognosis in LACC patients receiving CCRT. The integrated models with clinical characteristics further enhanced the predictive performance.
引用
- Cai C, Xiao JF, Cai R, et al. Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy. Radiat Oncol. 2024. PMID: 39707484. doi:10.1186/s13014-024-02574-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。